MCRB stock news
This page provides real-time market news, earnings updates, and company announcements related to Seres Therapeutics, Inc. (MCRB).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-13 21:12 EST
Hong Kong's e-HKD: Building a Digital Gateway Connecting China with International Markets
Bitget-RWA2025-10-29 05:30:06
Hong Kong Integrates Technology with National Strategies to Strengthen Its Position as a World Financial Leader
Bitget-RWA2025-10-30 01:56:10
Investors Turn to Blockchain as Meme Coins Struggle During Market Fluctuations
Bitget-RWA2025-11-02 12:44:10
Hong Kong Opens Global Cryptocurrency Opportunities to Compete with Singapore and the United States
Bitget-RWA2025-11-03 05:08:15
Major Banks Ratings | Goldman Sachs: BYD and XPeng Rated "Buy," Benefiting from Overseas Market Expansion
格隆汇2026-01-09 03:01:44
The Battle of Super Apps in the AI Era Begins | Zhou Yahui’s Investment Notes: AI Era Series Part 2
晚点Latepost2026-01-20 04:29:24
Biopharmaceutical company Seres Therapeutics, Inc. recently announced the implementation of a series of strategic adjustments aimed at extending its corporate operating cycle.
老虎证券2026-02-12 12:06:58
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
Finviz2026-02-12 12:06:41
Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash
Finviz2026-02-12 13:30:49
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
Finviz2026-03-02 21:09:42
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-12 11:03:48
Seres Therapeutics: Fourth Quarter Earnings Overview
101 finance2026-03-12 11:36:13
Seres Therapeutics: Q2 2026 SER-155 Data May Determine Survival or Dilution
101 finance2026-03-14 04:09:40
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
Finviz2026-03-17 20:09:45
Seres Therapeutics to Present at CARB-X Investor Day
Finviz2026-04-09 11:03:40
ZBIO Stalls as Analysts Split and Sector Fears Price Cuts
101 finance2026-04-10 01:00:49
Is Overlooked Biotech Ready to Surge? Making the Argument for Platform Strategies in a Shifting Industry
101 finance2026-04-11 04:57:44
Major Banks Ratings | Goldman Sachs: BYD and XPeng Rated "Buy," Benefiting from Overseas Market Expansion
格隆汇2026-01-09 03:01:44
The Battle of Super Apps in the AI Era Begins | Zhou Yahui’s Investment Notes: AI Era Series Part 2
晚点Latepost2026-01-20 04:29:24
Biopharmaceutical company Seres Therapeutics, Inc. recently announced the implementation of a series of strategic adjustments aimed at extending its corporate operating cycle.
老虎证券2026-02-12 12:06:58
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
Finviz2026-02-12 12:06:41
Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash
Finviz2026-02-12 13:30:49
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
Finviz2026-03-02 21:09:42
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-12 11:03:48
Seres Therapeutics: Fourth Quarter Earnings Overview
101 finance2026-03-12 11:36:13
Seres Therapeutics: Q2 2026 SER-155 Data May Determine Survival or Dilution
101 finance2026-03-14 04:09:40
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
Finviz2026-03-17 20:09:45
Seres Therapeutics to Present at CARB-X Investor Day
Finviz2026-04-09 11:03:40
ZBIO Stalls as Analysts Split and Sector Fears Price Cuts
101 finance2026-04-10 01:00:49
Is Overlooked Biotech Ready to Surge? Making the Argument for Platform Strategies in a Shifting Industry
101 finance2026-04-11 04:57:44
MCRB stock chart
MCRB stock detailsMCRB stock price change
On the last trading day, MCRB stock closed at 8.66 USD, with a price change of 4.09% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more